Target intelligence / Profile preview

Ankyrin repeat and ubiquitin domain-containing protein 1 (ANKUB1)

Target
ANKUB1
Molecular classification
Other (contains ankyrin repeat domains and a ubiquitin domain; not a receptor, enzyme, transporter, nor transcription factor)
01

Overview

Ankyrin repeat and ubiquitin domain-containing protein 1 (ANKUB1), also known as C3orf16, is a human protein characterized by the presence of three ankyrin repeat domains, a ubiquitin domain, and a low complexity region[1][3][9][11]. Ankyrin repeats are structural motifs known to mediate protein–protein interactions, while the ubiquitin domain is associated with protein turnover and signaling, typically through interactions involved in ubiquitinylation[1][9]. ANKUB1 is not currently established as a classical therapeutic target such as a receptor, ion channel, or enzyme, and there are no known drugs or targeted therapies against it[11][13]. Frameshift mutations in ANKUB1 have been observed in rare cases of familial polysyndactyly (PSD), implicating possible functions in developmental processes, though the exact biological role remains to be validated[1]. Data suggest that ANKUB1 might act in protein regulation or cellular signaling pathways; however, its precise physiological or pathological roles remain largely uncharacterized, and it is not widely recognized as a disease gene or biomarker[1][11][13].

Other names
C3orf16protein ANKUB1ANKUB1
02

Biological functions

Protein–protein interaction (via ankyrin repeat domains)Protein turnover or signaling (via ubiquitin domain)
03

Disease associations

Other (Potential link to polysyndactyly or skeletal development due to observed mutations in rare familial cases)Other (Gene fusion involving ANKUB1 observed in some tumors, but functional role in cancer not well established)

Beyond the preview

Go deeper on Ankyrin repeat and ubiquitin domain-containing protein 1 (ANKUB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and ubiquitin domain-containing protein 1 (ANKUB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call